PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis |
| Phenotype | C0039730|thalassemia |
| Sentences | 11 |
| PubMedID- 23745128 | In 2007, the prevalence of hepatitis c infection in patients with thalassemia in iran was between 63.8% and 15.7% (9). |
| PubMedID- 24282420 | The prevalence of chronic hepatitis c infection in patients with beta thalassemia major is 18%, particularly because of blood transfusion before hcv serological testing (1, 5). |
| PubMedID- 21845061 | Effect of hepatic iron concentration and viral factors in chronic hepatitis c-infected patients with thalassemia major, treated with interferon and ribavirin. |
| PubMedID- 24130600 | Of them, 80 were hepatitis c patients with beta thalassemia major and 50 were only hepatitis c patients. |
| PubMedID- 23293206 | Hepatocellular carcinoma in hepatitis-negative patients with thalassemia intermedia: a closer look at the role of siderosis. |
| PubMedID- 23082485 | Hepcidin levels and iron status in beta-thalassemia major patients with hepatitis c virus infection. |
| PubMedID- 22180419 | Il28b polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis c virus infection. |
| PubMedID- 22500658 | The incidence of hepatitis c in patients with thalassemia after screening in blood transfusion centers: a fourteen-year study. |
| PubMedID- 23412560 | hepatitis c in patients with beta-thalassemia major. |
| PubMedID- 23293194 | Conclusion: young beta thalassemia patients with active hepatitis c infection may have hepatic cirrhosis or fibrosis at young age when accompanied with hepatic siderosis. |
| PubMedID- 25653968 | Conclusion: the results of this study indicate that using 30 mg/day elemental zinc did not significantly improve the outcome of treatment in thalassemia patients with chronic hepatitis c. |
Page: 1